AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 157 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,597,000 | +88.3% | 964,759 | -6.7% | 0.34% | +98.2% |
| Q2 2022 | $7,754,000 | -17.4% | 1,033,852 | +0.3% | 0.17% | +1.8% |
| Q1 2022 | $9,383,000 | +80.5% | 1,031,065 | +39.3% | 0.17% | +84.4% |
| Q4 2021 | $5,197,000 | -34.0% | 740,263 | +7.2% | 0.09% | -37.9% |
| Q3 2021 | $7,869,000 | -29.5% | 690,279 | -1.0% | 0.14% | -28.2% |
| Q2 2021 | $11,162,000 | -9.3% | 697,204 | +1.3% | 0.20% | -14.0% |
| Q1 2021 | $12,303,000 | +22.0% | 688,487 | -7.7% | 0.24% | +14.6% |
| Q4 2020 | $10,081,000 | +63.4% | 746,197 | +42.4% | 0.20% | +40.4% |
| Q3 2020 | $6,168,000 | -22.2% | 524,060 | -2.4% | 0.15% | -25.5% |
| Q2 2020 | $7,929,000 | +39.9% | 537,170 | +28.0% | 0.20% | +14.0% |
| Q1 2020 | $5,666,000 | -50.2% | 419,723 | -10.8% | 0.17% | -30.9% |
| Q4 2019 | $11,375,000 | +30.1% | 470,625 | +3.5% | 0.25% | +20.9% |
| Q3 2019 | $8,740,000 | – | 454,750 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |